New Research Poster Presentation 2.48: Early Response Predicts Future Treatment Success During Aripiprazole Treatment of Adolescents with Schizophrenia

Thursday, October 29, 2009 8:30 AM

Christoph U. Correll, M.D., Psychiatry, The Zucker Hillside Hospital/Albert Einstein College of Medicine, Glen Oaks, NY

William Carson, M.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Margaretta Nyilas, M.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Robert A. Forbes, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Chien-Feng Chen, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Taro Iwamoto, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Raymond Mankoski, M.D., Ph.D., Bristol-Myers Squibb Company, Plainsboro, NJ

Suja Mathew, B.S., Otsuka America Pharmaceutical, Inc., Rockville, MD

Andrei Pikalov, M.D., Ph.D., Otsuka America Pharmaceutical, Inc., Rockville, MD

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 2.48 Early Response Predicts Future Treatment Success During Aripiprazole Treatment of Adolescents with Schizophrenia